1. Home >
  2. Amplity Health Acquires Middleton Access

M&A Deal Summary

Amplity Health Acquires Middleton Access

On December 13, 2021, Amplity Health acquired business services company Middleton Access

Acquisition Highlights
  • This is Amplity Health’s 1st transaction in the Business Services sector.
  • This is Amplity Health’s 2nd transaction in the United States.
  • This is Amplity Health’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2021-12-13
Target Middleton Access
Sector Business Services
Buyer(s) Amplity Health
Deal Type Add-on Acquisition

Target

Middleton Access

Burlington, Massachusetts, United States
Middleton Access is a Market Access consulting firm with a leading position in Federal Access. With deep and proven expertise to maximize coverage and adoption of pharmaceuticals. Middleton Access is based in Burlington, Massachusetts.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Amplity Health

Yardley, Pennsylvania, United States
Category Company
Sector Information Services
DESCRIPTION

Amplity Health is a pharmaceutical contract commercial services organization which provides customized, live channel healthcare sales, service and clinical solutions for pharmaceutical, biotechnology, medical device, and diagnostics companies and offers these services through a range of brands including Publicis Touchpoint Solutions, PDI, Tardis Medical, Phrequency, and CustomPoint Recruiting. Amplity Health is based in Yardley, Pennsylvania.

DEAL STATS #
Overall 2 of 2
Sector (Business Services) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (Massachusetts) 1 of 1
Country (United States) 2 of 2
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-22 RealHealthData

Santa Cruz, California, United States

RealHealthData is a technology company focused on providing unique, real world data insights. RealHealthData helps analyze existing unstructured data from physician notes, clinical trial research or other research to develop a de-identified dataset that can be customized to analyze any key words, trends or requirements.

Buy -
Mergr

Product

Company

Legal